ATMI gears up for single-use "boom" for biotech industry

Loading the player...

ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.

Speaking to in-PharmaTechnologist.com at this year's Interphex in New York, the firm's regional sales manager Brent Todd told us ATMI is now testing its 2D bags for biomanufacturing with helium, because an atom of the gas is smaller than a molecule of air, and therefore can detect smaller holes.

He said the move was a response to demand from clients and and the wider industry, who are increasingly opting for bags in downstream biomanufacturing processes.

"Obviously if you're using these bags more downstream the value of the content increases dramatically. So customers are obviously more interested in making sure they're not going to leak," he said.

The firm is now preparing to roll out helium integrity testing on its 3D line of storage vessels - including mixing bags, and bioreactor bags - within the next year.

Brent went on to herald the benefits of single-use technology in general, both for ATMI and the industry, branding it "game changing."

He said: "This is a way to increase your operational efficiency. You can only go so high in terms of improving your technology without making dramatic changes, but with implementing single-use technology you can go to that next level and really get some changes in your efficiency."

Related News

Single use tech for biopharma: Pall and Thermo Fisher

The quest for more understanding is behind the single use boom: Pall and Thermo Fisher

Catalent to replace steel bioreactors with single use

Catalent plans single use overhaul of bioreactors

ATMI single-use bioprocessing system

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI Adds New Single-Use Tech in Deal with CMO D-Lab

ATMI Adds New Single-Use Fill/Finish Tech in Deal with CMO D-Lab

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

ASI and Chromatan talk Single-use at NY Interphex

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI Opens US Bio development and testing Lab

ATMI Opens US Bio Development and Testing Lab

ATMI unveils helium integrity testing for bioprocess vessels at Interphex 2011

ATMI Finesses single-use bioreactors with process control tech deal

ATMI Finesses single-use bioreactors with process control tech deal

ATMI launches large-volume bioreactor with GMP compliance in mind

Related Products

See more related products